Dr. Barbaro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
120 Mineola Blvd
Mineola, NY 11501Phone+1 516-663-9500Fax+1 516-663-4613
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuro-Oncology, 2019 - 2021- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2016 - 2019
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 2015 - 2016
New York University School of MedicineClass of 2015
Certifications & Licensure
NY State Medical License 2018 - 2026
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant Astrocytomas.Matthew D Lee, Rajan Jain, Kristyn Galbraith, Anna Chen, Evan Lieberman
Clinical Cancer Research. 2024-08-15 - 1 citationsPrognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.Kristyn Galbraith, Mekka Garcia, Siyu Wei, Anna Chen, Chanel Schroff
Neuro-Oncology. 2024-06-03 - 7 citationsEvaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.Sylvia C Kurz, Elcin Zan, Christine Cordova, Andrea B Troxel, Marissa Barbaro
Clinical Cancer Research. 2024-02-16
Press Mentions
Top Neurosurgery Program Returns Rock Star to the StageDecember 2nd, 2022- Clinical Tumor Progression, Infection Common Causes of Death in Patients with GliomasNovember 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
